Literature DB >> 19275757

Role of the Akt pathway in prostate cancer.

Paul L de Souza1, Pamela J Russell, John Kearsley.   

Abstract

The Akt pathway, or more accurately, network, has assumed increasing importance with the understanding that it represents a key role in cancer cell survival and proliferation. Intense efforts to target proteins and enzymes within this pathway with highly selective compounds have led to the development of diverse agents now in Phase I-III clinical trials. Moreover, the notion that exploitation of multiple "druggable" targets simultaneously or in the appropriate sequence may provide better anti-tumour effects than single drugs hold promise that chemoresistance may be overcome, at least in part. This paper reviews important aspects of the Akt network, with a particular focus on prostate cancer biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275757     DOI: 10.2174/156800909787581006

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  10 in total

1.  Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Authors:  Vanessa Fritz; Zohra Benfodda; Geneviève Rodier; Corinne Henriquet; François Iborra; Christophe Avancès; Yves Allory; Alexandre de la Taille; Stéphane Culine; Hubert Blancou; Jean Paul Cristol; Françoise Michel; Claude Sardet; Lluis Fajas
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

2.  Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2.

Authors:  Kangdong Liu; Chanmi Park; Shengqing Li; Ki Won Lee; Haidan Liu; Long He; Nak Kyun Soung; Jong Seog Ahn; Ann M Bode; Ziming Dong; Bo Yeon Kim; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-04-24       Impact factor: 4.944

Review 3.  Novel targets for prostate cancer chemoprevention.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

4.  Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.

Authors:  Ryan Tasseff; Satyaprakash Nayak; Saniya Salim; Poorvi Kaushik; Noreen Rizvi; Jeffrey D Varner
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

5.  Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.

Authors:  Kangdong Liu; Chanmi Park; Hanyong Chen; Joonsung Hwang; N R Thimmegowda; Eun Young Bae; Ki Won Lee; Hong-Gyum Kim; Haidan Liu; Nak Kyun Soung; Cong Peng; Jae Hyuk Jang; Kyoon Eon Kim; Jong Seog Ahn; Ann M Bode; Ziming Dong; Bo Yeon Kim; Zigang Dong
Journal:  Mol Carcinog       Date:  2014-04-04       Impact factor: 4.784

6.  Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.

Authors:  Katsuyuki Iida; Rong Zheng; Ruoqian Shen; David M Nanus
Journal:  Int J Oncol       Date:  2012-08-08       Impact factor: 5.650

7.  Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.

Authors:  M Rumsby; J Schmitt; M Sharrard; G Rodrigues; M Stower; N Maitland
Journal:  Br J Cancer       Date:  2011-01-25       Impact factor: 7.640

Review 8.  The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.

Authors:  Gaetano Romano
Journal:  Scientifica (Cairo)       Date:  2013-12-05

9.  Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling.

Authors:  Hongwei Guo; Hua Luo; Hebao Yuan; Yudui Xia; Pan Shu; Xin Huang; Yi Lu; Xia Liu; Evan T Keller; Duxin Sun; Jiagang Deng; Jian Zhang
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

10.  Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2.

Authors:  Tze-chen Hsieh; Chia-Yi Lin; Dylan John Bennett; Erxi Wu; Joseph M Wu
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.